Facebook Linkedin RSS Twitter Youtube
Home 2011

Malaria vaccine

Asuragen Achieves CE Mark for AmplideX Genetic Test for Fragile X Syndrome
News

Asuragen Achieves CE Mark for AmplideX Genetic Test for Fragile X Syndrome

Novartis Completes $125M Acquisition of Majority Stake in Chinese Vaccines Firm
Drug Discovery

Novartis Completes $125M Acquisition of Majority Stake in Chinese Vaccines Firm

Crucell to Use Pepscan’s CLIPS Technology for Development of Infectious Disease Vaccines
Drug Discovery

Crucell to Use Pepscan’s CLIPS Technology for Development of Infectious Disease Vaccines

Overview of the Number Three and Four Biotech Clusters in the U.S.
Insights

Overview of the Number Three and Four Biotech Clusters in the U.S.

LGLS Licenses Novavax’ VLP Technology to Develop Flu Vaccines for South Korea and Other Emerging Markets
Bioprocessing

LGLS Licenses Novavax’ VLP Technology to Develop Flu Vaccines for South Korea and Other Emerging Markets

AFFiRiS Receives €3.5M from GSK with Preclinical Success in Alzheimer Vaccine Alliance
Drug Discovery

AFFiRiS Receives €3.5M from GSK with Preclinical Success in Alzheimer Vaccine Alliance

Roche Hands Phase IIb-Stage HPV Vaccine Back To Transgene
Cancer

Roche Hands Phase IIb-Stage HPV Vaccine Back To Transgene

Scientists Generate Pneumococcal Serotype 3 Vaccine Using Synthetic Toxin Gene
Bioprocessing

Scientists Generate Pneumococcal Serotype 3 Vaccine Using Synthetic Toxin Gene

SBS EpiTool Kit
Best of the Web

SBS EpiTool Kit

Inviragen and Duke-NUS Form Vaccine Partnership to Tackle Emerging Infectious Diseases
Drug Discovery

Inviragen and Duke-NUS Form Vaccine Partnership to Tackle Emerging Infectious Diseases

1234...9Page 3 of 9
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.